Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Texas Instruments (TXN) have what it takes? Let’s…
Author archives: Zacks Equity Research
Why Horizon Bancorp (HBNC) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horizon Bancorp (HBNC) have what it takes? Let’s…
HP (HPQ) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does HP (HPQ) have what it takes? Let’s find…
G or PAYX: Which Is the Better Value Stock Right Now?
G vs. PAYX: Which Stock Is the Better Value Option?
General Electric (GE) to Restructure Steam Power Portfolio
General Electric (GE) decides to reshape its steam power portfolio by divesting certain businesses to the EDF Group. It expects to record non-cash charges related to the deal.
ROKU Gears Up to Report Q4 Earnings: What’s in the Cards?
ROKU’s fourth-quarter 2021 performance is expected to reflect growth in active accounts and viewing, supported by increased advertiser demand for the company’s ad solutions.
Quidel (QDEL) to Report Q4 Earnings: What’s in the Offing?
Quidel’s (QDEL) fourth-quarter results are likely to reflect continued strength across its SARS-related products.
Russia – Ukraine Conflict Dents Wall Street’s Confidence
Russia – Ukraine Conflict Dents Wall Street’s Confidence.
Y-mAbs (YMAB) Stock Up on Pre-BLA Meeting Completion With FDA
Following a pre-BLA meeting with the FDA, Y-mAbs Therapeutics (YMAB) expects to resubmit its filing for omburtamabin CNS/leptomeningeal metastases from neuroblastoma by the end of first-quarter 2022.
Gilead (GILD) Veklury Retains Activity Against Omicron Variant
Gilead’s (GILD) Veklury (remdesivir) retains antiviral activity against Omicron, Delta and other emergent SARS-CoV-2 variants in multiple in vitro studies.